S. Tanik Et Al. , "Is the Neutrophil-Lymphocyte Ratio an Indicator of Progression in Patients with Benign Prostatic Hyperplasia?," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.15, pp.6375-6379, 2014
Tanik, S. Et Al. 2014. Is the Neutrophil-Lymphocyte Ratio an Indicator of Progression in Patients with Benign Prostatic Hyperplasia?. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.15 , 6375-6379.
Tanik, S., Albayrak, S., Zengin, K., Borekci, H., Bakirtas, H., Imamoglu, M. A., ... Gurdal, M.(2014). Is the Neutrophil-Lymphocyte Ratio an Indicator of Progression in Patients with Benign Prostatic Hyperplasia?. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.15, 6375-6379.
Tanik, Serhat Et Al. "Is the Neutrophil-Lymphocyte Ratio an Indicator of Progression in Patients with Benign Prostatic Hyperplasia?," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.15, 6375-6379, 2014
Tanik, Serhat Et Al. "Is the Neutrophil-Lymphocyte Ratio an Indicator of Progression in Patients with Benign Prostatic Hyperplasia?." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.15, pp.6375-6379, 2014
Tanik, S. Et Al. (2014) . "Is the Neutrophil-Lymphocyte Ratio an Indicator of Progression in Patients with Benign Prostatic Hyperplasia?." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.15, pp.6375-6379.
@article{article, author={Serhat Tanik Et Al. }, title={Is the Neutrophil-Lymphocyte Ratio an Indicator of Progression in Patients with Benign Prostatic Hyperplasia?}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2014, pages={6375-6379} }